| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1024431218327 |
| P698 | PubMed publication ID | 12880279 |
| P2093 | author name string | Andrew Johnson | |
| M Guillaume Wientjes | |||
| Jessie L S Au | |||
| Jeffrey S Johnston | |||
| Yuebo Gan | |||
| P2860 | cites work | Resistance to apoptosis in human cells conferred by telomerase function and telomere stability | Q22003740 |
| Telomere shortening and apoptosis in telomerase-inhibited human tumor cells | Q24598974 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| The RNA component of human telomerase | Q28288330 | ||
| Acute effects of 3'-azido-3'-deoxythymidine on the cell cycle of HL60 cells | Q28331325 | ||
| Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate | Q28369221 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| New colorimetric cytotoxicity assay for anticancer-drug screening | Q29615418 | ||
| Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation | Q31864098 | ||
| Role of telomerase in cell senescence and oncogenesis | Q33895976 | ||
| Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines | Q36556649 | ||
| Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death | Q36742412 | ||
| What is synergy? | Q38752149 | ||
| Telomeres: beginning to understand the end. | Q40383344 | ||
| Mitochondrial toxicity of antiviral drugs | Q40429889 | ||
| Doses and time-dependent effects of 3'-azido-3'-deoxythymidine on T47D human breast cancer cells in vitro | Q40843825 | ||
| Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. | Q41044843 | ||
| Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. | Q44302040 | ||
| Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation | Q47870828 | ||
| Telomere maintenance is dependent on activities required for end repair of double-strand breaks | Q47946099 | ||
| Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis | Q47995296 | ||
| Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells. | Q50517271 | ||
| Inhibition of telomerase limits the growth of human cancer cells. | Q52536487 | ||
| Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. | Q54169761 | ||
| Preferential incorporation of 3'-azido-2',3'-dideoxythymidine into telomeric DNA and Z-DNA-containing regions of Chinese hamster ovary cells | Q70477502 | ||
| Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity | Q72611356 | ||
| Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines | Q73851376 | ||
| Anti-apoptotic role of telomerase in pheochromocytoma cells | Q74583658 | ||
| P433 | issue | 7 | |
| P921 | main subject | zidovudine | Q198504 |
| paclitaxel | Q423762 | ||
| P304 | page(s) | 957-961 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells | |
| P478 | volume | 20 |
| Q40165886 | 3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell line. |
| Q36210474 | AZT as a telomerase inhibitor |
| Q44625238 | Alpha-hederin potentiates 5-FU antitumor activity in human colon adenocarcinoma cells |
| Q36735112 | Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer |
| Q55313430 | Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1. |
| Q89989620 | New drugs are not enough‑drug repositioning in oncology: An update |
| Q39794497 | Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin's lymphoma Raji cells and human hematopoietic stem/progenitor cells |
| Q39379394 | Telomerase and drug resistance in cancer. |
| Q28079188 | Telomerase as a Cancer Target. Development of New Molecules |
Search more.